Literature DB >> 8324433

Interactions between a general practitioner and representatives of drug companies.

B O'Mahony.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Year:  1993        PMID: 8324433      PMCID: PMC1678055          DOI: 10.1136/bmj.306.6893.1649

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Doctors and the drug industry: too close for comfort.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

2.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

3.  Doctors and detailers: therapeutic education or pharmaceutical promotion?

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1989       Impact factor: 1.663

4.  Doctors, drug companies, and gifts.

Authors:  M M Chren; C S Landefeld; T H Murray
Journal:  JAMA       Date:  1989 Dec 22-29       Impact factor: 56.272

  4 in total
  1 in total

Review 1.  Characteristics of materials distributed by drug companies. An evaluation of appropriateness.

Authors:  D Stryer; L A Bero
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.